Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 93

1.

N-homocysteinylation of tau and MAP1 is increased in autopsy specimens of Alzheimer's disease and vascular dementia.

Bossenmeyer-Pourié C, Smith AD, Lehmann S, Deramecourt V, Sablonnière B, Camadro JM, Pourié G, Kerek R, Helle D, Umoret R, Guéant-Rodriguez RM, Rigau V, Gabelle A, Sequeira JM, Quadros EV, Daval JL, Guéant JL.

J Pathol. 2019 Feb 8. doi: 10.1002/path.5254. [Epub ahead of print]

PMID:
30734924
2.

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.

Darlix A, Hirtz C, Thezenas S, Maceski A, Gabelle A, Lopez-Crapez E, De Forges H, Firmin N, Guiu S, Jacot W, Lehmann S.

BMC Cancer. 2019 Jan 30;19(1):110. doi: 10.1186/s12885-019-5287-z.

3.

Influence of activity space on the association between neighborhood characteristics and dementia risk: results from the 3-City study cohort.

Letellier N, Carrière I, Gutierrez LA, Gabelle A, Dartigues JF, Dufouil C, Helmer C, Cadot E, Berr C.

BMC Geriatr. 2019 Jan 7;19(1):4. doi: 10.1186/s12877-018-1017-7.

4.

Reduced brain amyloid burden in elderly patients with narcolepsy type 1.

Gabelle A, Jaussent I, Bouallègue FB, Lehmann S, Lopez R, Barateau L, Grasselli C, Pesenti C, de Verbizier D, Béziat S, Mariano-Goulart D, Carlander B, Dauvilliers Y; Alzheimer's Disease Neuroimaging Initiative; Multi-Domain Intervention Alzheimer's Prevention Trial study groups.

Ann Neurol. 2019 Jan;85(1):74-83. doi: 10.1002/ana.25373. Epub 2018 Dec 19.

PMID:
30387527
5.

Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ1-42 and Tau Proteins in Elderly Patients With Mild Cognitive Impairment.

Duron E, Vidal JS, Grousselle D, Gabelle A, Lehmann S, Pasquier F, Buée L, Allinquant B, Schraen-Maschke S, Baret C, Rigaud AS, Hanon O, Epelbaum J.

Front Aging Neurosci. 2018 Oct 1;10:297. doi: 10.3389/fnagi.2018.00297. eCollection 2018.

6.

HIV Neuroinfection and Alzheimer's Disease: Similarities and Potential Links?

Canet G, Dias C, Gabelle A, Simonin Y, Gosselet F, Marchi N, Makinson A, Tuaillon E, Van de Perre P, Givalois L, Salinas S.

Front Cell Neurosci. 2018 Sep 11;12:307. doi: 10.3389/fncel.2018.00307. eCollection 2018.

7.

Association of Long-Term Diet Quality with Hippocampal Volume: Longitudinal Cohort Study.

Akbaraly T, Sexton C, Zsoldos E, Mahmood A, Filippini N, Kerleau C, Verdier JM, Virtanen M, Gabelle A, Ebmeier KP, Kivimaki M.

Am J Med. 2018 Nov;131(11):1372-1381.e4. doi: 10.1016/j.amjmed.2018.07.001. Epub 2018 Jul 26.

8.

Alzheimer's Disease: Advances in Drug Development.

Piton M, Hirtz C, Desmetz C, Milhau J, Lajoix AD, Bennys K, Lehmann S, Gabelle A.

J Alzheimers Dis. 2018;65(1):3-13. doi: 10.3233/JAD-180145.

PMID:
30040716
9.

Neural correlates of episodic memory in the Memento cohort.

Epelbaum S, Bouteloup V, Mangin JF, La Corte V, Migliaccio R, Bertin H, Habert MO, Fischer C, Azouani C, Fillon L, Chupin M, Vellas B, Pasquier F, Dartigues JF, Blanc F, Gabelle A, Ceccaldi M, Krolak-Salmon P, Hugon J, Hanon O, Rouaud O, David R, Chêne G, Dubois B, Dufouil C.

Alzheimers Dement (N Y). 2018 May 22;4:224-233. doi: 10.1016/j.trci.2018.03.010. eCollection 2018.

10.

A Complex Relationship Between Suicide, Dementia, and Amyloid: A Narrative Review.

Conejero I, Navucet S, Keller J, Olié E, Courtet P, Gabelle A.

Front Neurosci. 2018 Jun 1;12:371. doi: 10.3389/fnins.2018.00371. eCollection 2018.

11.

Identification of multiple proteoforms biomarkers on clinical samples by routine Top-Down approaches.

Vialaret J, Schmit PO, Lehmann S, Gabelle A, Wood J, Bern M, Paape R, Suckau D, Kruppa G, Hirtz C.

Data Brief. 2018 Mar 31;18:1013-1021. doi: 10.1016/j.dib.2018.03.114. eCollection 2018 Jun.

12.

Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale.

Lehmann S, Delaby C, Boursier G, Catteau C, Ginestet N, Tiers L, Maceski A, Navucet S, Paquet C, Dumurgier J, Vanmechelen E, Vanderstichele H, Gabelle A.

Front Aging Neurosci. 2018 May 28;10:138. doi: 10.3389/fnagi.2018.00138. eCollection 2018.

13.

Anxiety and 10-Year Risk of Incident Dementia-An Association Shaped by Depressive Symptoms: Results of the Prospective Three-City Study.

Mortamais M, Abdennour M, Bergua V, Tzourio C, Berr C, Gabelle A, Akbaraly TN.

Front Neurosci. 2018 Apr 17;12:248. doi: 10.3389/fnins.2018.00248. eCollection 2018.

14.

Cross-sectional associations of plasma vitamin D with cerebral β-amyloid in older adults at risk of dementia.

Nourhashemi F, Hooper C, Cantet C, Féart C, Gennero I, Payoux P, Salabert AS, Guyonnet S, De Souto Barreto P, Vellas B; Multidomain Alzheimer Preventive Trial/Data sharing Alzheimer (DSA) study group.

Alzheimers Res Ther. 2018 Apr 25;10(1):43. doi: 10.1186/s13195-018-0371-1.

15.

Author Correction: Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates.

Bartolome F, Esteras N, Martin-Requero A, Boutoleau-Bretonniere C, Vercelletto M, Gabelle A, Ber IL, Honda T, Dinkova-Kostova AT, Hardy J, Carro E, Abramov AY.

Sci Rep. 2018 Mar 1;8(1):4064. doi: 10.1038/s41598-018-22152-9.

16.

Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.

Hanon O, Vidal JS, Lehmann S, Bombois S, Allinquant B, Tréluyer JM, Gelé P, Delmaire C, Blanc F, Mangin JF, Buée L, Touchon J, Hugon J, Vellas B, Galbrun E, Benetos A, Berrut G, Paillaud E, Wallon D, Castelnovo G, Volpe-Gillot L, Paccalin M, Robert PH, Godefroy O, Dantoine T, Camus V, Belmin J, Vandel P, Novella JL, Duron E, Rigaud AS, Schraen-Maschke S, Gabelle A; BALTAZAR study group.

Alzheimers Dement. 2018 Jul;14(7):858-868. doi: 10.1016/j.jalz.2018.01.004. Epub 2018 Feb 17.

17.

Cerebral microbleeds and CSF Alzheimer biomarkers in primary progressive aphasias.

Mendes A, Bertrand A, Lamari F, Colliot O, Routier A, Godefroy O, Etcharry-Bouyx F, Moreaud O, Pasquier F, Couratier P, Bennys K, Vercelletto M, Martinaud O, Laurent B, Pariente J, Puel M, Epelbaum S, Belliard S, Kaaouana T, Fillon L, Chupin M, Dubois B, Teichmann M; PHRC “CAPP” Study Group.

Neurology. 2018 Mar 20;90(12):e1057-e1065. doi: 10.1212/WNL.0000000000005165. Epub 2018 Feb 14.

PMID:
29444966
18.

Association between serum hepcidin level and restless legs syndrome.

Dauvilliers Y, Chenini S, Vialaret J, Delaby C, Guiraud L, Gabelle A, Lopez R, Hirtz C, Jaussent I, Lehmann S.

Mov Disord. 2018 Apr;33(4):618-627. doi: 10.1002/mds.27287. Epub 2018 Feb 8.

PMID:
29418021
19.

Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage.

Bousiges O, Bombois S, Schraen S, Wallon D, Quillard MM, Gabelle A, Lehmann S, Paquet C, Amar-Bouaziz E, Magnin E, Miguet-Alfonsi C, Delbeuck X, Lavaux T, Anthony P, Philippi N, Blanc F; ePLM network and collaborators.

J Neurol Neurosurg Psychiatry. 2018 May;89(5):467-475. doi: 10.1136/jnnp-2017-316385. Epub 2018 Jan 10.

PMID:
29321140
20.

Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers.

Vercruysse O, Paquet C, Gabelle A, Delbeuck X, Blanc F, Wallon D, Dumurgier J, Magnin E, Martinaud O, Jung B, Bousiges O, Lehmann S, Delaby C, Quillard-Murain M, Peoc H K, Laplanche JL, Bouaziz-Amar E, Hannequin D, Sablonniere B, Buee L, Hugon J, Schraen S, Pasquier F, Bombois S, For The E-Plm Group.

Curr Alzheimer Res. 2018;15(7):691-700. doi: 10.2174/1567205015666180110113238.

PMID:
29318973

Supplemental Content

Loading ...
Support Center